203 related articles for article (PubMed ID: 25976225)
1. Tanshinone IIA - loaded pellets developed for angina chronotherapy: Deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation.
Yan HX; Li J; Li ZH; Zhang WL; Liu JP
Eur J Pharm Sci; 2015 Aug; 76():156-64. PubMed ID: 25976225
[TBL] [Abstract][Full Text] [Related]
2. Development of protocatechualdehyde proliposomes-based sustained-release pellets with improved bioavailability and desired pharmacokinetic behavior for angina chronotherapy.
Zhang S; Yan H; Yu P; Xia Y; Zhang W; Liu J
Eur J Pharm Sci; 2016 Oct; 93():341-50. PubMed ID: 27568854
[TBL] [Abstract][Full Text] [Related]
3. Development of cryptotanshinone-loaded pellets for angina chronotherapy:
Li Z; Zhang S; Yan H; Liu J
Asian J Pharm Sci; 2018 Jul; 13(4):310-316. PubMed ID: 32104404
[TBL] [Abstract][Full Text] [Related]
4. Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation.
Li J; Liu P; Liu JP; Zhang WL; Yang JK; Fan YQ
Eur J Pharm Biopharm; 2012 Feb; 80(2):426-32. PubMed ID: 22119664
[TBL] [Abstract][Full Text] [Related]
5. Release behavior of tanshinone IIA sustained-release pellets based on crack formation theory.
Liu P; Li J; Liu J; Yang J; Fan Y
J Pharm Sci; 2012 Aug; 101(8):2811-20. PubMed ID: 22610467
[TBL] [Abstract][Full Text] [Related]
6. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
Zhang WL; Liu JP; Liu XX; Chen ZQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
[TBL] [Abstract][Full Text] [Related]
7. Tailoring therapeutic effect for chronotherapy of variant angina based on pharmacodynamic/deconvolution integrated model method.
Li Z; Li Z; Yu H; Wang B; Song W; Liu J
Eur J Pharm Sci; 2022 Aug; 175():106208. PubMed ID: 35577181
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
[TBL] [Abstract][Full Text] [Related]
9. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pharmacokinetic and pharmacodynamic relationship for oral sustained-release atenolol pellets in rats.
Jia J; Dong C; Zhang W; Cui Y; Liu J
J Pharm Biomed Anal; 2011 May; 55(2):342-8. PubMed ID: 21353427
[TBL] [Abstract][Full Text] [Related]
11. Tanshinol sustained-release pellets with absorption enhancer: optimization, characterization, pharmacokinetics and pharmacodynamics.
Yu P; Zhang S; Zhang W; Yang J; Lu J; Liu J
Drug Dev Ind Pharm; 2017 Jul; 43(7):1093-1102. PubMed ID: 28165803
[TBL] [Abstract][Full Text] [Related]
12. Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release.
Ensslin S; Moll KP; Metz H; Otz M; Mäder K
Eur J Pharm Biopharm; 2009 May; 72(1):111-8. PubMed ID: 19084061
[TBL] [Abstract][Full Text] [Related]
13. New insight into modified release pellets - Internal structure and drug release mechanism.
Ensslin S; Moll KP; Paulus K; Mäder K
J Control Release; 2008 Jun; 128(2):149-56. PubMed ID: 18433911
[TBL] [Abstract][Full Text] [Related]
14. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets.
Kendre PN; Chaudhari PD
Drug Dev Ind Pharm; 2017 May; 43(5):751-761. PubMed ID: 27494543
[TBL] [Abstract][Full Text] [Related]
15. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
16. Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells.
Lin J; Wang X; Wu Q; Dai J; Guan H; Cao W; He L; Wang Y
Int J Pharm; 2014 Feb; 462(1-2):11-8. PubMed ID: 24374609
[TBL] [Abstract][Full Text] [Related]
17. Preparation and IVIVC evaluation of salvianolic acid B micro-porous osmotic pump pellets.
Kan SL; Li J; Liu JP; Zhao Y
Drug Dev Ind Pharm; 2015 Mar; 41(3):476-81. PubMed ID: 24467406
[TBL] [Abstract][Full Text] [Related]
18. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
19. Application of ethyl cellulose, microcrystalline cellulose and octadecanol for wax based floating solid dispersion pellets.
Yan HX; Zhang SS; He JH; Liu JP
Carbohydr Polym; 2016 Sep; 148():143-52. PubMed ID: 27185125
[TBL] [Abstract][Full Text] [Related]
20. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
